Literature DB >> 2476109

Epitope mapping of the Lassa virus nucleoprotein using monoclonal anti-nucleocapsid antibodies.

F T Hufert1, W Lüdke, H Schmitz.   

Abstract

Monoclonal antibodies with differing specificity were prepared against the Josiah strain of the Lassa virus. All monoclonal antibodies were characterized by subclass determination and the immunofluorescence test against Lassa, LCM (WE & Arm strain), Junin, Machupo, and other arenavirus antigens. In radioimmune precipitation tests using purified Lassa virus antigen all monoclonal antibodies precipitated a single band of 60 kd, specific for the viral nucleoprotein (p 60). Three domains (A, B, C) were identified on the surface of the Lassa virus nucleoprotein using an ELISA-inhibition test. All domains carried different Lassa virus specific epitopes. In addition, the A-domain carried a group specific epitope present within the arenavirus family as a whole as shown by cross-reaction in immunofluorescence tests. The B-domain only carries Lassa virus specific epitopes, whereas the C-domain has a type specific and a subgroup specific (Lassa, LCM) epitope.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2476109     DOI: 10.1007/bf01313953

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  20 in total

1.  Cross reactivity between Junin and Tacaribe viruses as determined by neutralization test and immunoprecipitation.

Authors:  E B Damonte; S E Mersich; N A Candurra; C E Coto
Journal:  Med Microbiol Immunol       Date:  1986       Impact factor: 3.402

2.  Epidemiology and control of Lassa fever.

Authors:  J B McCormick
Journal:  Curr Top Microbiol Immunol       Date:  1987       Impact factor: 4.291

3.  Interrelationships among arenaviruses measured by indirect immunofluorescence.

Authors:  H Wolff; J V Lange; P A Webb
Journal:  Intervirology       Date:  1978       Impact factor: 1.763

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Use of monoclonal antibody for the detection of Lassa virus antibody and antigen in patients with Lassa fever.

Authors:  H Schmitz; H R Wolf
Journal:  Med Microbiol Immunol       Date:  1986       Impact factor: 3.402

6.  Characterization of polypeptides immunoprecipitable from Pichinde virus-infected BHK-21 cells.

Authors:  D G Harnish; W C Leung; W E Rawls
Journal:  J Virol       Date:  1981-06       Impact factor: 5.103

7.  Inactivation of Lassa, Marburg, and Ebola viruses by gamma irradiation.

Authors:  L H Elliott; J B McCormick; K M Johnson
Journal:  J Clin Microbiol       Date:  1982-10       Impact factor: 5.948

8.  Lassa fever, a new virus disease of man from West Africa. 3. Isolation and characterization of the virus.

Authors:  S M Buckley; J Casals
Journal:  Am J Trop Med Hyg       Date:  1970-07       Impact factor: 2.345

9.  Vaccinia recombinant expressing Lassa-virus internal nucleocapsid protein protects guineapigs against Lassa fever.

Authors:  J C Clegg; G Lloyd
Journal:  Lancet       Date:  1987-07-25       Impact factor: 79.321

10.  Machupo virus polypeptides: identification by immunoprecipitation.

Authors:  I S Lukashevich; N N Lemeshko
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

View more
  21 in total

1.  An N-terminal region of Lassa virus L protein plays a critical role in transcription but not replication of the virus genome.

Authors:  Michaela Lelke; Linda Brunotte; Carola Busch; Stephan Günther
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

2.  Characterization of human CD4(+) T-cell clones recognizing conserved and variable epitopes of the Lassa virus nucleoprotein.

Authors:  J ter Meulen; M Badusche; K Kuhnt; A Doetze; J Satoguina; T Marti; C Loeliger; K Koulemou; L Koivogui; H Schmitz; B Fleischer; A Hoerauf
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

3.  Detection of Lassa virus RNA in specimens from patients with Lassa fever by using the polymerase chain reaction.

Authors:  K Lunkenheimer; F T Hufert; H Schmitz
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

4.  Imported lassa fever in Germany: molecular characterization of a new lassa virus strain.

Authors:  S Günther; P Emmerich; T Laue; O Kühle; M Asper; A Jung; T Grewing; J ter Meulen; H Schmitz
Journal:  Emerg Infect Dis       Date:  2000 Sep-Oct       Impact factor: 6.883

5.  Shedding of soluble glycoprotein 1 detected during acute Lassa virus infection in human subjects.

Authors:  Luis M Branco; Jessica N Grove; Lina M Moses; Augustine Goba; Mohammed Fullah; Mambu Momoh; Randal J Schoepp; Daniel G Bausch; Robert F Garry
Journal:  Virol J       Date:  2010-11-09       Impact factor: 4.099

6.  Inhibition of different Lassa virus strains by alpha and gamma interferons and comparison with a less pathogenic arenavirus.

Authors:  Marcel Asper; Thomas Sternsdorf; Meike Hass; Christian Drosten; Antje Rhode; Herbert Schmitz; Stephan Günther
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

7.  Detection of Lassa virus antinucleoprotein immunoglobulin G (IgG) and IgM antibodies by a simple recombinant immunoblot assay for field use.

Authors:  J Ter Meulen; K Koulemou; T Wittekindt; K Windisch; S Strigl; S Conde; H Schmitz
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

8.  Lassa serology in natural populations of rodents and horizontal transmission.

Authors:  Elisabeth Fichet-Calvet; Beate Becker-Ziaja; Lamine Koivogui; Stephan Günther
Journal:  Vector Borne Zoonotic Dis       Date:  2014-09       Impact factor: 2.133

9.  Experimental Morogoro Virus Infection in Its Natural Host, Mastomys natalensis.

Authors:  Chris Hoffmann; Stephanie Wurr; Elisa Pallasch; Sabrina Bockholt; Toni Rieger; Stephan Günther; Lisa Oestereich
Journal:  Viruses       Date:  2021-05-07       Impact factor: 5.048

10.  Validation of Inactivation Methods for Arenaviruses.

Authors:  Silke Olschewski; Anke Thielebein; Chris Hoffmann; Olivia Blake; Jonas Müller; Sabrina Bockholt; Elisa Pallasch; Julia Hinzmann; Stephanie Wurr; Neele Neddersen; Toni Rieger; Stephan Günther; Lisa Oestereich
Journal:  Viruses       Date:  2021-05-24       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.